Vericel Corp. (VCEL)
38.09
-0.08
(-0.21%)
USD |
NASDAQ |
Feb 20, 16:00
38.15
+0.06
(+0.16%)
After-Hours: 20:00
Vericel Profit Margin (Quarterly) : 7.52% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -162.1% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Agenus, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.44% |
| Return on Assets | 3.06% |
| Return on Invested Capital | 3.31% |
| Gross Profit Margin (Quarterly) | 73.46% |
| Operating Margin (Quarterly) | 5.11% |
| Return on Net Operating Assets | 5.17% |